Home
/
STANDARD BIOTOOLS INC.
/
Financials
/
Quarterly
STANDARD BIOTOOLS INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that STANDARD BIOTOOLS INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2018
Jun 30, 2018
$26.43M
Aug 8, 2018
Q1
2018
Mar 31, 2018
$25.25M
May 8, 2018
Q3
2017
Sep 30, 2017
$24.75M
Nov 7, 2017
Q2
2018
Jun 30, 2017
$23.91M
Aug 8, 2018
Q1
2018
Mar 31, 2017
$25.53M
May 8, 2018
Q3
2017
Sep 30, 2016
$22.19M
Nov 7, 2017
Q2
2017
Jun 30, 2016
$28.17M
Aug 8, 2017
Q1
2017
Mar 31, 2016
$29.00M
May 9, 2017
Q3
2016
Sep 30, 2015
$28.64M
Nov 9, 2016
Q2
2016
Jun 30, 2015
$28.62M
Aug 9, 2016
Q1
2016
Mar 31, 2015
$26.73M
May 9, 2016
Q3
2015
Sep 30, 2014
$29.64M
Nov 9, 2015
Q2
2015
Jun 30, 2014
$27.61M
Aug 10, 2015
Q1
2015
Mar 31, 2014
$25.72M
May 11, 2015
Q3
2014
Sep 30, 2013
$18.29M
Nov 6, 2014
Q2
2014
Jun 30, 2013
$17.48M
Aug 4, 2014
Q1
2014
Mar 31, 2013
$14.54M
May 12, 2014
Q3
2013
Sep 30, 2012
$12.78M
Nov 7, 2013
Q2
2013
Jun 30, 2012
$12.95M
Aug 7, 2013
Q1
2013
Mar 31, 2012
$10.95M
May 9, 2013
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$19.55M
Nov 4, 2025
Q2
2025
Jun 30, 2025
$21.76M
Aug 15, 2025
Q1
2025
Mar 31, 2025
$40.80M
May 6, 2025
Q3
2025
Sep 30, 2024
$22.09M
Nov 4, 2025
Q2
2025
Jun 30, 2024
$22.49M
Aug 15, 2025
Q3
2024
Mar 31, 2024
$45.54M
May 9, 2024
Q1
2025
Mar 31, 2024
$45.54M
May 6, 2025
Q3
2024
Sep 30, 2023
$25.37M
Nov 6, 2024
Q2
2024
Jun 30, 2023
$27.67M
Aug 6, 2024
Q3
2024
Mar 31, 2023
$25.12M
May 9, 2024
Q1
2023
Mar 31, 2023
$25.12M
May 9, 2023
Q3
2023
Sep 30, 2022
$25.65M
Nov 7, 2023
Q2
2023
Jun 30, 2022
$18.78M
Aug 8, 2023
Q1
2023
Mar 31, 2022
$26.50M
May 9, 2023
Q3
2022
Sep 30, 2021
$28.50M
Nov 9, 2022
Q2
2022
Jun 30, 2021
$31.02M
Aug 9, 2022
Q1
2022
Mar 31, 2021
$32.79M
May 9, 2022
Q3
2021
Sep 30, 2020
$39.86M
Nov 9, 2021
Q2
2021
Jun 30, 2020
$26.06M
Aug 6, 2021
Q1
2021
Mar 31, 2020
$27.62M
May 7, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($34.69M)
Nov 4, 2025
Q3
2025
Jun 30, 2025
($33.46M)
Nov 4, 2025
Q2
2025
Jun 30, 2025
($33.46M)
Aug 15, 2025
Q2
2025
Mar 31, 2025
($26.03M)
Aug 15, 2025
Q1
2025
Mar 31, 2025
($26.03M)
May 6, 2025
Q3
2025
Mar 31, 2025
($26.03M)
Nov 4, 2025
Q3
2025
Sep 30, 2024
($26.94M)
Nov 4, 2025
Q2
2025
Jun 30, 2024
($45.72M)
Aug 15, 2025
Q3
2025
Jun 30, 2024
($45.72M)
Nov 4, 2025
Q1
2025
Mar 31, 2024
($32.16M)
May 6, 2025
Q2
2025
Mar 31, 2024
($32.16M)
Aug 15, 2025
Q3
2025
Mar 31, 2024
($32.16M)
Nov 4, 2025
Q3
2024
Sep 30, 2023
($21.00M)
Nov 6, 2024
Q2
2024
Jun 30, 2023
($17.04M)
Aug 6, 2024
Q3
2024
Jun 30, 2023
($17.04M)
Nov 6, 2024
Q1
2023
Mar 31, 2023
($16.84M)
May 9, 2023
Q3
2024
Mar 31, 2023
($16.84M)
Nov 6, 2024
Q2
2024
Mar 31, 2023
($16.84M)
Aug 6, 2024
Q3
2023
Sep 30, 2022
($29.43M)
Nov 7, 2023
Q3
2023
Jun 30, 2022
($63.54M)
Nov 7, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($32.94M)
Nov 4, 2025
Q2
2025
Jun 30, 2025
($25.70M)
Aug 15, 2025
Q1
2025
Mar 31, 2025
($32.97M)
May 6, 2025
Q3
2025
Sep 30, 2024
($26.70M)
Nov 4, 2025
Q2
2025
Jun 30, 2024
($30.26M)
Aug 15, 2025
Q3
2024
Mar 31, 2024
($60.18M)
May 9, 2024
Q1
2025
Mar 31, 2024
($60.18M)
May 6, 2025
Q3
2024
Sep 30, 2023
($21.17M)
Nov 6, 2024
Q2
2024
Jun 30, 2023
($17.45M)
Aug 6, 2024
Q1
2023
Mar 31, 2023
($16.59M)
May 9, 2023
Q3
2024
Mar 31, 2023
($16.59M)
May 9, 2024
Q3
2023
Sep 30, 2022
($29.03M)
Nov 7, 2023
Q2
2023
Jun 30, 2022
($38.56M)
Aug 8, 2023
Q1
2023
Mar 31, 2022
($27.50M)
May 9, 2023
Q3
2022
Sep 30, 2021
($19.61M)
Nov 9, 2022
Q2
2022
Jun 30, 2021
($17.27M)
Aug 9, 2022
Q1
2022
Mar 31, 2021
($19.32M)
May 9, 2022
Q3
2021
Sep 30, 2020
($5.46M)
Nov 9, 2021
Q2
2021
Jun 30, 2020
($13.73M)
Aug 6, 2021
Q1
2021
Mar 31, 2020
($14.94M)
May 7, 2021